Shire PLC (LON:SHP)‘s stock had its “buy” rating reiterated by Shore Capital in a report released on Wednesday.

SHP has been the topic of a number of other reports. JPMorgan Chase & Co. reaffirmed an “overweight” rating and set a GBX 6,300 ($82.23) target price on shares of Shire PLC in a report on Tuesday, August 16th. BNP Paribas reaffirmed an “outperform” rating and set a GBX 5,700 ($74.40) target price on shares of Shire PLC in a report on Wednesday, June 15th. Deutsche Bank AG reaffirmed a “buy” rating and set a GBX 5,600 ($73.10) target price on shares of Shire PLC in a report on Monday, June 13th. Morgan Stanley reissued an “overweight” rating and issued a GBX 5,600 ($73.10) price target on shares of Shire PLC in a research note on Friday, June 3rd. Finally, Jefferies Group lifted their price target on Shire PLC from GBX 6,050 ($78.97) to GBX 6,600 ($86.15) and gave the stock a “buy” rating in a research note on Wednesday, August 3rd. One research analyst has rated the stock with a sell rating, one has given a hold rating, sixteen have assigned a buy rating and one has given a strong buy rating to the company. The company has a consensus rating of “Buy” and an average price target of GBX 5,828 ($76.07).

Analyst Recommendations for Shire PLC (LON:SHP)

Shares of Shire PLC (LON:SHP) opened at 5117.00 on Wednesday. The company’s 50-day moving average is GBX 4,984.38 and its 200-day moving average is GBX 4,495.01. The firm’s market cap is GBX 34.94 billion. Shire PLC has a 52-week low of GBX 2,707.19 and a 52-week high of GBX 5,377.00.

The company also recently declared a dividend, which will be paid on Friday, October 7th. Stockholders of record on Thursday, September 8th will be issued a dividend of GBX 3.51 ($0.05) per share. The ex-dividend date of this dividend is Thursday, September 8th. This represents a dividend yield of 0.07%.

In other news, insider Bohuon,Olivier purchased 134 shares of Shire PLC stock in a transaction dated Thursday, June 30th. The stock was acquired at an average cost of GBX 4,463 ($58.26) per share, for a total transaction of £5,980.42 ($7,806.32).

Shire PLC Company Profile

Shire plc is a biotech company. The Company, along with its subsidiaries, is engaged in developing and marketing medicines for patients with rare diseases and other select conditions. The Company operates in the segment of research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines.

Receive News & Stock Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related stocks with our FREE daily email newsletter.